2019 Annual Report
2019 was a busy but exciting year for the Institute for Glycomics. From the laboratory bench to the patient’s bedside, translational outcomes are the ultimate goal of the Institute for Glycomics, and our research teams yielded very promising results throughout the year. Download our 2019 Annual Report to read more about our exciting research highlights and remarkable achievements that year.
2018 Annual Report
Our research is yielding new insights into our understanding of the changes important to the onset and development of cancers; and how infectious diseases evade the immune system and develop resistance to antimicrobials. Download our 2018 Annual Report to read more about our exciting research highlights and publications that year.
2017 Annual Report
2017 was a good year for our Institute with a number of discoveries, from both our drug and vaccine research programs, progressing into pre-clinical and
human clinical trials. These discoveries seek to tackle some of the most challenging human diseases, including malaria, viral-induced arthritis and sepsis as detailed in this report. The Institute’s mission is to be a translational medical research institute and these trials reinforce our mission.